{"id":91066,"date":"2026-05-19T16:54:07","date_gmt":"2026-05-19T11:24:07","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=91066"},"modified":"2026-05-19T16:54:08","modified_gmt":"2026-05-19T11:24:08","slug":"strides-pharma-science-q4-fy26-results","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/strides-pharma-science-q4-fy26-results\/","title":{"rendered":"Strides Pharma Science Q4 FY26 Results: PAT Rs 129 Cr, Revenue Rs 1,323 Crore"},"content":{"rendered":"<div class=\"meta-block\"><\/div>\n<p><strong><a href=\"https:\/\/univest.in\/user\/stocks\/star\/strides-pharma-science-ltd-share-price-today\">Strides Pharma Science<\/a> Q4 FY26<\/strong> results were declared on May 18, 2026, at the board of directors meeting. Strides Pharma Science reported PAT of Rs 129 crore for the quarter ended March 31, 2026, up 50.0% YoY from Rs 86 crore in Q4 FY25, on revenue of Rs 1,323 crore. Strides Pharma Science operates in the pharmaceutical formulations and APIs sector. Investors tracking Strides Pharma Science Q4 FY26 will find complete financial analysis and FY27 outlook in this article.<\/p>\n<p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/strides-pharma-science-q4-fy26-results\/#Strides_Pharma_Science_Q4_FY26_Financial_Highlights\" title=\"Strides Pharma Science Q4 FY26 Financial Highlights\">Strides Pharma Science Q4 FY26 Financial Highlights<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/strides-pharma-science-q4-fy26-results\/#Strides_Pharma_Science_Q4_FY26_Performance_Analysis\" title=\"Strides Pharma Science Q4 FY26 Performance Analysis\">Strides Pharma Science Q4 FY26 Performance Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/strides-pharma-science-q4-fy26-results\/#Key_Factors_for_the_company\" title=\"Key Factors for the company\">Key Factors for the company<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/strides-pharma-science-q4-fy26-results\/#Revenue_and_Sector_Dynamics\" title=\"Revenue and Sector Dynamics\">Revenue and Sector Dynamics<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/strides-pharma-science-q4-fy26-results\/#Profitability_and_Margin_Trends\" title=\"Profitability and Margin Trends\">Profitability and Margin Trends<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/strides-pharma-science-q4-fy26-results\/#FY27_Business_Outlook\" title=\"FY27 Business Outlook\">FY27 Business Outlook<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/strides-pharma-science-q4-fy26-results\/#Frequently_Asked_Questions_on_Strides\" title=\"Frequently Asked Questions on Strides\">Frequently Asked Questions on Strides<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/strides-pharma-science-q4-fy26-results\/#What_is_the_company_PAT\" title=\"What is the company PAT?\">What is the company PAT?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/strides-pharma-science-q4-fy26-results\/#What_is_the_company_revenue\" title=\"What is the company revenue?\">What is the company revenue?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/strides-pharma-science-q4-fy26-results\/#When_were_Strides_results_announced\" title=\"When were Strides results announced?\">When were Strides results announced?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/strides-pharma-science-q4-fy26-results\/#Is_Strides_Pharma_Science_a_good_investment_after_Q4_FY26\" title=\"Is Strides Pharma Science a good investment after Q4 FY26?\">Is Strides Pharma Science a good investment after Q4 FY26?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Strides_Pharma_Science_Q4_FY26_Financial_Highlights\"><\/span><strong>Strides Pharma Science Q4 FY26 Financial Highlights<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table>\n<tbody>\n<tr>\n<th>Metric<\/th>\n<th>Q4 FY26<\/th>\n<th>Comparison<\/th>\n<\/tr>\n<tr>\n<td><strong>PAT (Net Profit)<\/strong><\/td>\n<td>Rs 129 crore<\/td>\n<td>up 50.0% YoY from Rs 86 crore in Q4 FY25<\/td>\n<\/tr>\n<tr>\n<td><strong>Revenue from Operations<\/strong><\/td>\n<td>Rs 1,323 crore<\/td>\n<td>Quarter ended March 31, 2026<\/td>\n<\/tr>\n<tr>\n<td><strong>Ticker<\/strong><\/td>\n<td><\/td>\n<td>Sector: Pharmaceuticals<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Strides_Pharma_Science_Q4_FY26_Performance_Analysis\"><\/span><strong>Strides Pharma Science Q4 FY26 Performance Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Strides Pharma Science Q4 FY26 reflects the company&#8217;s operational performance during the January to March 2026 quarter. Strides Pharma Science is a leading pharmaceutical formulations and APIs company whose Q4 FY26 print sets the baseline for FY27 guidance. The profitability improvement demonstrates effective operating leverage and cost management. Q4 January to March is typically a seasonally strong quarter for Indian companies driven by year-end government procurement and project completion cycles.<\/p>\n<p>Investors tracking Strides will monitor FY27 revenue guidance, margin trajectory, and management commentary. Track Strides Pharma Science on the Univest Screener for live data.<\/p>\n<p><a href=\"https:\/\/univest.in\/screeners\"><strong>Check the Univest Screener for live data<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Factors_for_the_company\"><\/span><strong>Key Factors for the company<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Revenue_and_Sector_Dynamics\"><\/span><strong>Revenue and Sector Dynamics<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Strides revenue of Rs 1,323 crore reflects the company&#8217;s execution in the pharmaceutical formulations and APIs space. India&#8217;s sustained economic growth of 6.5%+ and robust domestic demand across sectors provide a supportive backdrop for FY27 business planning.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Profitability_and_Margin_Trends\"><\/span><strong>Profitability and Margin Trends<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The company PAT of Rs 129 crore up 50.0% YoY from Rs 86 crore in Q4 FY25 demonstrates consistent earnings delivery and improving profitability metrics. Management commentary on FY27 capex and growth investments will guide the stock&#8217;s near-term trajectory.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"FY27_Business_Outlook\"><\/span><strong>FY27 Business Outlook<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Following the firm results, management guidance on FY27 revenue, order book, and strategic priorities will be key catalysts. Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to receive SEBI-registered analyst research on Strides Pharma Science.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions_on_Strides\"><\/span><strong>Frequently Asked Questions on Strides<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_company_PAT\"><\/span><strong>What is the company PAT?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Strides reported PAT of Rs 129 crore up 50.0% YoY from Rs 86 crore in Q4 FY25. Results declared May 18, 2026. Full details from NSE\/BSE regulatory filings. Verify all data before investing.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_company_revenue\"><\/span><strong>What is the company revenue?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong style=\"color: initial;\">Ans.<\/strong><span style=\"color: initial;\"> The firm&#8217;s revenue from operations was Rs 1,323 crore for the quarter ended March 31, 2026.<\/span>\u00a0Track live on the Univest Screener.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"When_were_Strides_results_announced\"><\/span><strong>When were Strides results announced?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The company results were announced on May 18, 2026, at the board meeting approving audited Q4 and FY26 financial statements for the year ended March 31, 2026.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Strides_Pharma_Science_a_good_investment_after_Q4_FY26\"><\/span><strong>Is Strides Pharma Science a good investment after Q4 FY26?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Investment decisions require individual assessment of fundamentals, valuation, sector dynamics, and personal risk tolerance. This article does not constitute investment advice. Consult a SEBI-registered financial advisor before investing.<\/p>\n<p><em>Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Strides Pharma Science Q4 FY26 results May 18 2026. PAT of Rs 129 crore up 50.0% YoY from Rs 86 crore in Q4 FY25. Revenue Rs 1,323 crore. Full analysis.<\/p>\n","protected":false},"author":26,"featured_media":91757,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-91066","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_edit_lock":["1779189862:26"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["842"],"rank_math_seo_score":["76"],"rank_math_focus_keyword":["Strides Pharma Science Q4"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"rank_math_title":["Strides Pharma Science Q4 FY26: PAT Rs 129 Cr"],"rank_math_description":["Strides Pharma Science Q4 FY26 results May 18 2026. PAT of Rs 129 crore up 50.0% YoY from Rs 86 crore in Q4 FY25. Revenue Rs 1,323 crore. Full analysis."],"_thumbnail_id":["91757"],"_edit_last":["26"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["12334"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/05\/19165344\/Strides-Pharma-Science-Q4-FY26-Results.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/91066","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/26"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=91066"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/91066\/revisions"}],"predecessor-version":[{"id":91758,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/91066\/revisions\/91758"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/91757"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=91066"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=91066"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=91066"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}